ABCB1 and ovarian carcinoma: Meanwhile, the exon 21 MDR-1 polymorphism G2677T/A was confirmed to be associated with the paclitaxel response in ovarian cancer, including P-glycoprotein function and paclitaxel resistance, which provides useful information for individualized therapy of ovarian cancer (Green et al., 2006).